ConnectiveRx VP of Investor Relations Salaries in Hagerstown, MD | Comparably
ConnectiveRx Claimed Company
At ConnectiveRx we take the pain out of the prescription process. We don’t treat patients and we don’t make the medications that do. We use both innovation and human empathy to cut through mountains of red tape and create access to specialty medications for patients who have chronic disease—taking a process that can be expensive and difficult and making it as painless as possible. As one single partner, we connect patients with prescribed medications through hub services, affordability, awareness, and adherence solutions. The result? Happier patients who have a stronger connection to their medication brand. We've done this for hundreds of pharma companies and more than 530 drug brands. Let us facilitate great patient-to-drug experiences that make you shine. read more
EMPLOYEE
PARTICIPANTS
16
TOTAL
RATINGS
149
HR or Marketing? Claim Your Free Employer Account

ConnectiveRx VP of Investor Relations Salaries in Hagerstown, MD

The average ConnectiveRx VP of Investor Relations in Hagerstown, MD earns an estimated $127,525 annually. ConnectiveRx's VP of Investor Relations compensation is $3,883 less than the US average for a VP of Investor Relations.

In Hagerstown, MD, The Communications Department at ConnectiveRx earns $16,737 more on average than the Customer Support Department.

Last updated 7 months ago.

$77k
$120k
$129k
$225k
$127,525
Average Compensation
$127,525
avg. base

VP of Investor Relations Salaries at ConnectiveRx

In Hagerstown, MD, VPs of Investor Relations earn $47,566 more than Editors.

Editor
$80k*
* estimated salary

Compensation at ConnectiveRx by Department

In Hagerstown, MD, The Communications Department averages $16,737 more than the Customer Support Department, and $1,572 less than the Sales Department

Sales
$78,866 Avg. total comp.
+$2k
Communications
$77,294 Avg. total comp.
Customer Support
$60,557 Avg. total comp.
-$17k

How VPs of Investor Relations at ConnectiveRx Rate Their Compensation

The majority of VPs of Investor Relations at ConnectiveRx believe they're not compensated fairly. The vast majority (83%) of VPs of Investor Relations at ConnectiveRx are satisfied with their benefits. See more compensation ratings at ConnectiveRx

×
Rate your company